Abstract:OBJECTIVE:To investigate an inhibitive effect of the chitosan nanoparticles with the proliferation cell nuclear antigen (PCNA)-antisense oligo deoxy nucleotides (ASODN) on the intimal cell proliferation after the vein grafting. METHODS:Fifty-four male SD rats, weighing 450-600 g, were randomly divided in the experimental group and the control group of 27 rats each. In the experimental group, the chitosan nanoparticles with PCNA-ASODN were infused into the anastomosis segment of the right jugular artery and vein; then, the anastomosis segment was transplanted to the jugular artery on the same side. The rats in the control group were infused with normal saline by the same procedures. There were 24 rats in each group which used to experiment. The hemodynamic data were obtained from the Doppler ultrasound examinations at 1, 2, 3 and 4 weeks. The specimens were taken. Immunohistochemistry, Western-blot, and blood-vessel-wall histopathology were performed at the different week points. RESULTS:There was no significant difference in the thrombogenesis rate between the experimental group and the control group (3/27 vs. 3/27, P > 0.05). During the 4-week observation, PCNA Western-blot showed that the PCNA level was lower in the grafted vein and the anastomosis segment in the experimental group than in the control group. The indexes of the PCNA-postive proliferating cells in the intimal area (0.13% +/- 0.11%, 0.79% +/- 0.28%, 0.45% +/- 0.29%, 0.43% +/- 0.25%) and the medial area (1.90% +/- 0.84%, 2.11% +/- 0.98%, 2.48% +/- 0.77%, 2.17% +/- 0.36%) were significantly decreased at 1, 2, 3 and 4 weeks in the experimental group when compared with those in the control group (P < 0.05). The lumen areas in the grafted vein (88.71 +/- 16.96, 95.98 +/- 21.44, 88.48 +/- 32.81, 97.86 +/- 34. 11 microm2) and the anastomosis segment (41.49 +/- 3.34, 45.15 +/- 11.65, 46.27 +/- 8.90, 51.62 +/- 8.85 microm2) were significantly greater in the experimental group than in the control group (P < 0.05). The ratios of the initmal area to the medial area in the grafted vein (22.73% +/- 3.11%, 32.40% +/- 4.55%, 45.14% +/- 3.19%, 45.70% +/- 5.01%) and the anastomsis segment (41.49% +/- 3.34%, 45.15% +/- 11.65%, 46.27% +/- 8.90%, 51.62% +/- 8.85%) were significantly smaller in the experimental group than in the control group (P < 0.05). The maximum velocities (Vmax) of the blood flow in the grafted vein and the anastomsis segment were almost the same in the two groups at 1 week, but had different changes at the next 3 week-points. In the control group, the Vmax of the blood flow gradually increased and at 3 weeks it reached the peak point; however, at 4 weeks it decreased. In the experimental group, the Vmax of the blood flow gradually decreased, and at 3 weeks it decreased to the lowest point; however, at 4 weeks it increased. So, at 4 weeks the Vmax of the blood flow in the grafted vein and the anastomsis segment was almost the same in the two groups. There was no significant difference in the Vmax of the blood flow between the two groups (P > 0.05), but in the same group there was a significant difference at the different time points. CONCLUSION:The chitosan nanoparticles with PCNA-ASODN can effectively inhibit the intimal cell proliferation after the grafting of the blood vessel, so that the neointimal thickening can be prevented.

[Preventive Effect of Gene Therapy with Pro-Uk Gene on the Formation of Intimal Hyperplasia of Vascular Anastomotic Site].

[Effects of Platelet Derived Growth Factor Antisense Oligodeoxynucleotides and Tissue-Type Plasminogen Activator Gene Transfection on Inhibition of Intimal Proliferation].

[To Study the Effects of Local Co-Transfection Vascular Endothelial Growth Factor165 and Tissue-Type Plasminogen Activator Genes on Inhibiting Intimal Hyperplasia after Operation Injury Artery in Rabbits].

[The Study on Platelet-Derived Growth Factor and Proliferating Cell Nuclear Antigen Antisense Oligodeoxynucleotides Together Inhibiting the Stenosis of Transplanted Vascular].

[Inhibition of Intimal Proliferation after Vein Grafting by Chitosan Nanoparticle with Proliferation Cell Nuclear Antigen-Antisense Oligo Deoxy Nucleotides].

[Study on inhibiting the intimal hyperplasia after rabbit artery injury by local transfection of tissue-type plasminogen activator gene].

Intravascular Magnetic Resonance/radiofrequency May Enhance Gene Therapy for Prevention of In-Stent Neointimal Hyperplasia.

[Effects of Fusion Gene Encoding the Hvegf165 and Fused Hirudin on Restenosis of Injured Carotid Artery Induced by Angioplasty].

Promotive effect of polytetrafluoroethylene vascular grafts carrying VEGF gene on the growth of endothelial cells

Local transfer of stromal cell-derived factor-1α gene inhibits microsurgical anastomotic thrombosis

Empirical Study of Transfecting Early Growth Response Gene‐1 DNA Enzyme to Prevent Intimal Hyperlasia of Autogenous Vein Graft in Rats

The Effect of Adenovirus-Mediated Local Human Tissue Factor Pathway Inhibitor Gene on In-Stent Restenosis

Stimulation of Nitric Oxide Production Contributes to the Antithrombotic Effect of Stromal Cell–Derived Factor-1α in Preventing Microsurgical Anastomotic Thrombosis

Effect of Inhibiting Perivascular Adhesion on Intimal Hyperplasia of the Vein Grafts in Rabbits

A Preliminary Study of the Therapeutic Role of Human Early Fetal Aorta-derived Endothelial Progenitor Cells in Inhibiting Carotid Artery Neointimal Hyperplasia.

Effects of endothelial nitric oxide synthase gene transfection on neointima hyperplasia after vascular injury

Intravascular site-specific delivery of a therapeutic antisense for the inhibition of restenosis

Study on Inhibittonal Effect of Endothelial Nitric Oxide Synthase Gent Transfer on Neointimal Proliferation of Artery after Hal-Ion Injury

Controlled release of siRNA nanoparticles loaded in a novel external stent prepared by emulsion electrospinning attenuates neointima hyperplasia in vein grafts

[Gene therapy for the treatment of restenosis after coronary angioplasty]

Atorvastatin Reduces Accumulation of Vascular Smooth Muscle Cells to Inhibit Intimal Hyperplasia Via P38 MAPK Pathway Inhibition in a Rat Model of Vein Graft.